ACC 2019: ODYSSEY OUTCOMES Trial - Prof Vera Bittner
ODYSSEY OUTCOMES | ACC.19
ACC.18 | ODYSSEY Outcomes
ESC TV at ACC.18 - Perspective - ODYSSEY Outcomes Trial
ODYSSEY OUTCOMES. Alirocumab
ACC-ODYSSEY HOW TO BATTLE & PREVAIL ON BATLEGROUND!
Wouter Jukema, MD, PhD: ODYSSEY OUTCOMES in Post-Acute Coronary Syndrome
The ODYSSEY Outcomes Trial in CVD
Cost-Effectiveness of Alirocumab: A Just-in-Time Analysis Based on the ODYSSEY Outcomes Trial.
Evolut Low Risk | ACC.19
ORION Trial
ACC 2018: Alirocumab In Patients After Acute Coronary Syndrome
Day 1 Highlights | ACC.19
AUGUSTUS | ACC.19
ODYSSEY Patrick O'Gara, MD
GLASSY | ACC.19
COACT | ACC.19
DRF 24: ACC Latebreakers - ODYSSEY
TREAT | ACC.19
CCC 2019: ACUTE CORONARY SYNDROMES AND LIPID MANAGEMENT 2020: THE DECADE AHEAD